Improving Pharmacogenetic Testing in Primary Care for Underserved Patients
Author Information
Author(s): Bryan Emma G., Lunsford Kelsey, Mullis Michaela D., McFarlane Antionette, Elwood Erica, Gawronski Brian E., Duarte Julio D., Fisher Carla L., Lee Su-Jun, Myers Alan L.
Primary Institution: University of Florida
Hypothesis
What are the preferences of patients who have experienced pharmacogenetic testing to inform its implementation in primary care?
Conclusion
Patients prefer pre-emptive pharmacogenetic testing as it is proactive, expedites treatment, and is convenient.
Supporting Evidence
- Patients supported pre-emptive testing for being proactive about future health needs.
- Participants valued having immediate access to medications while avoiding side effects.
- Patients expressed a need for clear communication from clinicians regarding their test results.
Takeaway
This study found that patients like getting genetic tests done before they need medication, so doctors can help them faster and avoid bad side effects.
Methodology
Qualitative study using thematic analysis of interviews with 25 primary care patients from clinics serving medically underserved populations.
Limitations
The sample was predominantly female and lacked racial diversity, which may limit generalizability.
Participant Demographics
{"gender_distribution":{"female":19,"male":6},"age_range":"38-77","average_age":60,"racial_distribution":{"White":13,"Black":11,"Mixed Race":1},"employment_status":{"not_employed":20,"retired":11,"disabled":9},"education_level":{"high_school_or_less":8,"some_college_or_associate_degree":15},"income":{"42k_or_less":56}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website